お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は中枢神経系の治療市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは中枢神経系の治療の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の中枢神経系の治療市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは中枢神経系の治療のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に中枢神経系の治療市場を分類しています。本研究に含まれる主な企業は：Pfizer、Janssen Pharmaceuticals、Allergan、Lundbeck、Teva、Camber Pharmaceuticals、Zhejiang Haisen Pharmaceutical、Jewim Pharmaceutical、Cipla、Merck Sharp & Dohme Corp.、Eli Lilly、GlaxoSmithKline、Novartis、LUPIN、ZYDUS PHARMS、Biogen、Otsuka Pharmaceutical、Astra Zeneca、Takeda

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Neurodegenerative Diseases
    Mood Disorders
    Schizophrenia
    Autism
    Depression

用途別の市場セグメント：
    Hospital Use
    Clinic Use
    Household
    Other

本レポートの詳細内容
世界の中枢神経系の治療市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、中枢神経系の治療タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の中枢神経系の治療収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の中枢神経系の治療市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、中枢神経系の治療市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

中枢神経系の治療のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：中枢神経系の治療のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：中枢神経系の治療の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章中枢神経系の治療企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：中枢神経系の治療の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：中枢神経系の治療の主要企業の概要を提供し、製品の説明と仕様、中枢神経系の治療の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the ability to function. The condition may be an inherited metabolic disorder; the result of damage from an infection, a degenerative condition, stroke, a brain tumor or other problem; or arise from unknown or multiple factors. Movement disorders such as Parkinson’s disease, dystonia, and essential tremor are central nervous system conditions. What they have in common is the loss of sufficient, intact nervous system circuits that orchestrate functions as varied as memory formation (in Alzheimer’s) or voluntary motion (in movement disorders).
Market Analysis and Insights: Global CNS Therapeutics Market
The global CNS Therapeutics market is projected to grow from US$ 80250 million in 2024 to US$ 106190 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for CNS Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of CNS Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for CNS Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the CNS Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global CNS Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for CNS Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer, Janssen Pharmaceuticals, Allergan, Lundbeck, Teva, Camber Pharmaceuticals, Zhejiang Haisen Pharmaceutical, Jewim Pharmaceutical and Cipla, etc.

Market Segmentation
By Company
    Pfizer
    Janssen Pharmaceuticals
    Allergan
    Lundbeck
    Teva
    Camber Pharmaceuticals
    Zhejiang Haisen Pharmaceutical
    Jewim Pharmaceutical
    Cipla
    Merck Sharp & Dohme Corp.
    Eli Lilly
    GlaxoSmithKline
    Novartis
    LUPIN
    ZYDUS PHARMS
    Biogen
    Otsuka Pharmaceutical
    Astra Zeneca
    Takeda

Segment by Type
    Neurodegenerative Diseases
    Mood Disorders
    Schizophrenia
    Autism
    Depression

Segment by Application
    Hospital Use
    Clinic Use
    Household
    Other

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of CNS Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CNS Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CNS Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global CNS Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Neurodegenerative Diseases
    Table 3. Key Players of Mood Disorders
    Table 4. Key Players of Schizophrenia
    Table 5. Key Players of Autism
    Table 6. Key Players of Depression
    Table 7. Global CNS Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 8. Global CNS Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global CNS Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global CNS Therapeutics Market Share by Region (2019-2024)
    Table 11. Global CNS Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global CNS Therapeutics Market Share by Region (2025-2030)
    Table 13. CNS Therapeutics Market Trends
    Table 14. CNS Therapeutics Market Drivers
    Table 15. CNS Therapeutics Market Challenges
    Table 16. CNS Therapeutics Market Restraints
    Table 17. Global CNS Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global CNS Therapeutics Revenue Share by Players (2019-2024)
    Table 19. Global Top CNS Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CNS Therapeutics as of 2023)
    Table 20. Global CNS Therapeutics Industry Ranking 2022 VS 2023 VS 2024
    Table 21. Global 5 Largest Players Market Share by CNS Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Global Key Players of CNS Therapeutics, Headquarters and Area Served
    Table 23. Global Key Players of CNS Therapeutics, Product and Application
    Table 24. Global Key Players of CNS Therapeutics, Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global CNS Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global CNS Therapeutics Revenue Market Share by Type (2019-2024)
    Table 28. Global CNS Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global CNS Therapeutics Revenue Market Share by Type (2025-2030)
    Table 30. Global CNS Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global CNS Therapeutics Revenue Share by Application (2019-2024)
    Table 32. Global CNS Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global CNS Therapeutics Revenue Share by Application (2025-2030)
    Table 34. North America CNS Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 35. North America CNS Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 36. North America CNS Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 37. North America CNS Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 38. North America CNS Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. North America CNS Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 40. North America CNS Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Europe CNS Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 42. Europe CNS Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 43. Europe CNS Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 44. Europe CNS Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 45. Europe CNS Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Europe CNS Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Europe CNS Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 48. China CNS Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 49. China CNS Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 50. China CNS Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 51. China CNS Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 52. Asia CNS Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 53. Asia CNS Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 54. Asia CNS Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 55. Asia CNS Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 56. Asia CNS Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 57. Asia CNS Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 58. Asia CNS Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America CNS Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America CNS Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America CNS Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America CNS Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America CNS Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 64. Middle East, Africa, and Latin America CNS Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America CNS Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 66. Pfizer Company Details
    Table 67. Pfizer Business Overview
    Table 68. Pfizer CNS Therapeutics Product
    Table 69. Pfizer Revenue in CNS Therapeutics Business (2019-2024) & (US$ Million)
    Table 70. Pfizer Recent Developments
    Table 71. Janssen Pharmaceuticals Company Details
    Table 72. Janssen Pharmaceuticals Business Overview
    Table 73. Janssen Pharmaceuticals CNS Therapeutics Product
    Table 74. Janssen Pharmaceuticals Revenue in CNS Therapeutics Business (2019-2024) & (US$ Million)
    Table 75. Janssen Pharmaceuticals Recent Developments
    Table 76. Allergan Company Details
    Table 77. Allergan Business Overview
    Table 78. Allergan CNS Therapeutics Product
    Table 79. Allergan Revenue in CNS Therapeutics Business (2019-2024) & (US$ Million)
    Table 80. Allergan Recent Developments
    Table 81. Lundbeck Company Details
    Table 82. Lundbeck Business Overview
    Table 83. Lundbeck CNS Therapeutics Product
    Table 84. Lundbeck Revenue in CNS Therapeutics Business (2019-2024) & (US$ Million)
    Table 85. Lundbeck Recent Developments
    Table 86. Teva Company Details
    Table 87. Teva Business Overview
    Table 88. Teva CNS Therapeutics Product
    Table 89. Teva Revenue in CNS Therapeutics Business (2019-2024) & (US$ Million)
    Table 90. Teva Recent Developments
    Table 91. Camber Pharmaceuticals Company Details
    Table 92. Camber Pharmaceuticals Business Overview
    Table 93. Camber Pharmaceuticals CNS Therapeutics Product
    Table 94. Camber Pharmaceuticals Revenue in CNS Therapeutics Business (2019-2024) & (US$ Million)
    Table 95. Camber Pharmaceuticals Recent Developments
    Table 96. Zhejiang Haisen Pharmaceutical Company Details
    Table 97. Zhejiang Haisen Pharmaceutical Business Overview
    Table 98. Zhejiang Haisen Pharmaceutical CNS Therapeutics Product
    Table 99. Zhejiang Haisen Pharmaceutical Revenue in CNS Therapeutics Business (2019-2024) & (US$ Million)
    Table 100. Zhejiang Haisen Pharmaceutical Recent Developments
    Table 101. Jewim Pharmaceutical Company Details
    Table 102. Jewim Pharmaceutical Business Overview
    Table 103. Jewim Pharmaceutical CNS Therapeutics Product
    Table 104. Jewim Pharmaceutical Revenue in CNS Therapeutics Business (2019-2024) & (US$ Million)
    Table 105. Jewim Pharmaceutical Recent Developments
    Table 106. Cipla Company Details
    Table 107. Cipla Business Overview
    Table 108. Cipla CNS Therapeutics Product
    Table 109. Cipla Revenue in CNS Therapeutics Business (2019-2024) & (US$ Million)
    Table 110. Cipla Recent Developments
    Table 111. Merck Sharp & Dohme Corp. Company Details
    Table 112. Merck Sharp & Dohme Corp. Business Overview
    Table 113. Merck Sharp & Dohme Corp. CNS Therapeutics Product
    Table 114. Merck Sharp & Dohme Corp. Revenue in CNS Therapeutics Business (2019-2024) & (US$ Million)
    Table 115. Merck Sharp & Dohme Corp. Recent Developments
    Table 116. Eli Lilly Company Details
    Table 117. Eli Lilly Business Overview
    Table 118. Eli Lilly CNS Therapeutics Product
    Table 119. Eli Lilly Revenue in CNS Therapeutics Business (2019-2024) & (US$ Million)
    Table 120. Eli Lilly Recent Developments
    Table 121. GlaxoSmithKline Company Details
    Table 122. GlaxoSmithKline Business Overview
    Table 123. GlaxoSmithKline CNS Therapeutics Product
    Table 124. GlaxoSmithKline Revenue in CNS Therapeutics Business (2019-2024) & (US$ Million)
    Table 125. GlaxoSmithKline Recent Developments
    Table 126. Novartis Company Details
    Table 127. Novartis Business Overview
    Table 128. Novartis CNS Therapeutics Product
    Table 129. Novartis Revenue in CNS Therapeutics Business (2019-2024) & (US$ Million)
    Table 130. Novartis Recent Developments
    Table 131. LUPIN Company Details
    Table 132. LUPIN Business Overview
    Table 133. LUPIN CNS Therapeutics Product
    Table 134. LUPIN Revenue in CNS Therapeutics Business (2019-2024) & (US$ Million)
    Table 135. LUPIN Recent Developments
    Table 136. ZYDUS PHARMS Company Details
    Table 137. ZYDUS PHARMS Business Overview
    Table 138. ZYDUS PHARMS CNS Therapeutics Product
    Table 139. ZYDUS PHARMS Revenue in CNS Therapeutics Business (2019-2024) & (US$ Million)
    Table 140. ZYDUS PHARMS Recent Developments
    Table 141. Biogen Company Details
    Table 142. Biogen Business Overview
    Table 143. Biogen CNS Therapeutics Product
    Table 144. Biogen Revenue in CNS Therapeutics Business (2019-2024) & (US$ Million)
    Table 145. Biogen Recent Developments
    Table 146. Otsuka Pharmaceutical Company Details
    Table 147. Otsuka Pharmaceutical Business Overview
    Table 148. Otsuka Pharmaceutical CNS Therapeutics Product
    Table 149. Otsuka Pharmaceutical Revenue in CNS Therapeutics Business (2019-2024) & (US$ Million)
    Table 150. Otsuka Pharmaceutical Recent Developments
    Table 151. Astra Zeneca Company Details
    Table 152. Astra Zeneca Business Overview
    Table 153. Astra Zeneca CNS Therapeutics Product
    Table 154. Astra Zeneca Revenue in CNS Therapeutics Business (2019-2024) & (US$ Million)
    Table 155. Astra Zeneca Recent Developments
    Table 156. Takeda Company Details
    Table 157. Takeda Business Overview
    Table 158. Takeda CNS Therapeutics Product
    Table 159. Takeda Revenue in CNS Therapeutics Business (2019-2024) & (US$ Million)
    Table 160. Takeda Recent Developments
    Table 161. Research Programs/Design for This Report
    Table 162. Key Data Information from Secondary Sources
    Table 163. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global CNS Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global CNS Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. Neurodegenerative Diseases Features
    Figure 4. Mood Disorders Features
    Figure 5. Schizophrenia Features
    Figure 6. Autism Features
    Figure 7. Depression Features
    Figure 8. Global CNS Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global CNS Therapeutics Market Share by Application: 2023 VS 2030
    Figure 10. Hospital Use Case Studies
    Figure 11. Clinic Use Case Studies
    Figure 12. Household Case Studies
    Figure 13. Other Case Studies
    Figure 14. CNS Therapeutics Report Years Considered
    Figure 15. Global CNS Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 16. Global CNS Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global CNS Therapeutics Market Share by Region: 2023 VS 2030
    Figure 18. Global CNS Therapeutics Market Share by Players in 2023
    Figure 19. Global Top CNS Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CNS Therapeutics as of 2023)
    Figure 20. The Top 10 and 5 Players Market Share by CNS Therapeutics Revenue in 2023
    Figure 21. North America CNS Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. North America CNS Therapeutics Market Share by Type (2019-2030)
    Figure 23. North America CNS Therapeutics Market Share by Application (2019-2030)
    Figure 24. North America CNS Therapeutics Market Share by Country (2019-2030)
    Figure 25. United States CNS Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Canada CNS Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Europe CNS Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 28. Europe CNS Therapeutics Market Share by Type (2019-2030)
    Figure 29. Europe CNS Therapeutics Market Share by Application (2019-2030)
    Figure 30. Europe CNS Therapeutics Market Share by Country (2019-2030)
    Figure 31. Germany CNS Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. France CNS Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. U.K. CNS Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Italy CNS Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Russia CNS Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Nordic Countries CNS Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. China CNS Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. China CNS Therapeutics Market Share by Type (2019-2030)
    Figure 39. China CNS Therapeutics Market Share by Application (2019-2030)
    Figure 40. Asia CNS Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 41. Asia CNS Therapeutics Market Share by Type (2019-2030)
    Figure 42. Asia CNS Therapeutics Market Share by Application (2019-2030)
    Figure 43. Asia CNS Therapeutics Market Share by Region (2019-2030)
    Figure 44. Japan CNS Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. South Korea CNS Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. China Taiwan CNS Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia CNS Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. India CNS Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Australia CNS Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America CNS Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 51. Middle East, Africa, and Latin America CNS Therapeutics Market Share by Type (2019-2030)
    Figure 52. Middle East, Africa, and Latin America CNS Therapeutics Market Share by Application (2019-2030)
    Figure 53. Middle East, Africa, and Latin America CNS Therapeutics Market Share by Country (2019-2030)
    Figure 54. Brazil CNS Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Mexico CNS Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Turkey CNS Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Saudi Arabia CNS Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Israel CNS Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. GCC Countries CNS Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. Pfizer Revenue Growth Rate in CNS Therapeutics Business (2019-2024)
    Figure 61. Janssen Pharmaceuticals Revenue Growth Rate in CNS Therapeutics Business (2019-2024)
    Figure 62. Allergan Revenue Growth Rate in CNS Therapeutics Business (2019-2024)
    Figure 63. Lundbeck Revenue Growth Rate in CNS Therapeutics Business (2019-2024)
    Figure 64. Teva Revenue Growth Rate in CNS Therapeutics Business (2019-2024)
    Figure 65. Camber Pharmaceuticals Revenue Growth Rate in CNS Therapeutics Business (2019-2024)
    Figure 66. Zhejiang Haisen Pharmaceutical Revenue Growth Rate in CNS Therapeutics Business (2019-2024)
    Figure 67. Jewim Pharmaceutical Revenue Growth Rate in CNS Therapeutics Business (2019-2024)
    Figure 68. Cipla Revenue Growth Rate in CNS Therapeutics Business (2019-2024)
    Figure 69. Merck Sharp & Dohme Corp. Revenue Growth Rate in CNS Therapeutics Business (2019-2024)
    Figure 70. Eli Lilly Revenue Growth Rate in CNS Therapeutics Business (2019-2024)
    Figure 71. GlaxoSmithKline Revenue Growth Rate in CNS Therapeutics Business (2019-2024)
    Figure 72. Novartis Revenue Growth Rate in CNS Therapeutics Business (2019-2024)
    Figure 73. LUPIN Revenue Growth Rate in CNS Therapeutics Business (2019-2024)
    Figure 74. ZYDUS PHARMS Revenue Growth Rate in CNS Therapeutics Business (2019-2024)
    Figure 75. Biogen Revenue Growth Rate in CNS Therapeutics Business (2019-2024)
    Figure 76. Otsuka Pharmaceutical Revenue Growth Rate in CNS Therapeutics Business (2019-2024)
    Figure 77. Astra Zeneca Revenue Growth Rate in CNS Therapeutics Business (2019-2024)
    Figure 78. Takeda Revenue Growth Rate in CNS Therapeutics Business (2019-2024)
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed